Hopefully big new is coming, page-30

First 30 Last

Plext

10,508 Posts.

1244

30/06/22

11:16

Post #: 62292187

Originally posted by alecfra ↑

wow G08 will be a major benefactor hear

Column 1

0

Column 1

0

Column 1

0
COVIRIX Medical Holdings Ltd. is raising capital at A$2.80

[/table]

Column 1

0

Column 1

0

Column 1

0

[/table][/table]

Column 1

0

Column 1

0
Pre-IPO opportunity in COVID-related antiviral product

[/table]

Column 1

0

Column 1

0

Column 1

0

[/table][/table]

Column 1

0

Column 1

0
Covirix Medical Holdings Ltd is seeking expressions of interest in raising A$14m pre-IPO through the issue of 5m shares at A$2.80 to fund Phase I & II clinical trials on repurposed antivirals for COVID.

[/table]

Column 1

0

Column 1

0

Column 1

0

[/table][/table]

Column 1

0

Column 1

0 KEY POINTS:

[/table]

Column 1

0

Column 1

0

Column 1

0

[/table][/table]

Column 1

0

Column 1

0 1. CVX-20733 is an antiviral FDA-approved drug for another disease application. 2. Covirix is repurposing it as an inhalable small molecule broad spectrum drug for COVID-19. 3. Agreements in place to carry out Phase I & II Clinical trials in India and Nepal. 4. Repurposing will significantly reduce risk and timeline to market. 5. Revenue potential is large and no competitor yet identified. 6. Sole Aust/NZ distributor US supplier DiaCarta Inc’s Rapid Antigen & PCR Tests. 7. Listing and secondary listing planned for Australia and Hong Kong. 8. Pitt Street Research valuation of US$5.46 – US$8.45 per share.

[/table][/table]

Expand

CVX-20733 is an antiviral FDA-approved drug !

Very keen to see if they can make a goer of this and get that capital raised.
Governments need to do more to set these kinds of treatments, especially if they are already FDA approved.

$8.45 a share U$D ! LOL

G08 is at .006 AUD a share right now ! double lol !!